Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

A microRNA profile of human CD8(+) regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • الموضوع:
      2014
    • Collection:
      Université de Lausanne (UNIL): Serval - Serveur académique lausannois
    • نبذة مختصرة :
      Recently, regulatory T (Treg) cells have gained interest in the fields of immunopathology, transplantation and oncoimmunology. Here, we investigated the microRNA expression profile of human natural CD8(+)CD25(+) Treg cells and the impact of microRNAs on molecules associated with immune regulation. We purified human natural CD8(+) Treg cells and assessed the expression of FOXP3 and CTLA-4 by flow cytometry. We have also tested the ex vivo suppressive capacity of these cells in mixed leukocyte reactions. Using TaqMan low-density arrays and microRNA qPCR for validation, we could identify a microRNA 'signature' for CD8(+)CD25(+)FOXP3(+)CTLA-4(+) natural Treg cells. We used the 'TargetScan' and 'miRBase' bioinformatics programs to identify potential target sites for these microRNAs in the 3'-UTR of important Treg cell-associated genes. The human CD8(+)CD25(+) natural Treg cell microRNA signature includes 10 differentially expressed microRNAs. We demonstrated an impact of this signature on Treg cell biology by showing specific regulation of FOXP3, CTLA-4 and GARP gene expression by microRNA using site-directed mutagenesis and a dual-luciferase reporter assay. Furthermore, we used microRNA transduction experiments to demonstrate that these microRNAs impacted their target genes in human primary Treg cells ex vivo. We are examining the biological relevance of this 'signature' by studying its impact on other important Treg cell-associated genes. These efforts could result in a better understanding of the regulation of Treg cell function and might reveal new targets for immunotherapy in immune disorders and cancer.
    • File Description:
      application/pdf
    • ISSN:
      1479-5876
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/25090912; info:eu-repo/semantics/altIdentifier/eissn/1479-5876; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D16C5369C6485; https://serval.unil.ch/notice/serval:BIB_D16C5369C648; urn:issn:1479-5876; https://serval.unil.ch/resource/serval:BIB_D16C5369C648.P001/REF.pdf; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D16C5369C6485
    • الرقم المعرف:
      10.1186/s12967-014-0218-x
    • Rights:
      info:eu-repo/semantics/openAccess ; Copying allowed only for non-profit organizations ; https://serval.unil.ch/disclaimer
    • الرقم المعرف:
      edsbas.C929FCD5